Goldman Sachs’s Candel Therapeutics CADL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $402K | Buy |
79,405
+24,739
| +45% | +$125K | ﹤0.01% | 4379 |
|
|
2025
Q1 | $309K | Sell |
54,666
-10,570
| -16% | -$59.7K | ﹤0.01% | 4494 |
|
|
2024
Q4 | $566K | Buy |
65,236
+34,975
| +116% | +$304K | ﹤0.01% | 4234 |
|
|
2024
Q3 | $210K | Buy |
30,261
+12,036
| +66% | +$83.4K | ﹤0.01% | 4474 |
|
|
2024
Q2 | $113K | Buy |
+18,225
| New | +$113K | ﹤0.01% | 4486 |
|
|
2022
Q3 | – | Sell |
-10,037
| Closed | -$33K | – | 5490 |
|
|
2022
Q2 | $33K | Sell |
10,037
-473
| -5% | -$1.56K | ﹤0.01% | 5355 |
|
|
2022
Q1 | $53K | Sell |
10,510
-83
| -0.8% | -$419 | ﹤0.01% | 5459 |
|
|
2021
Q4 | $83K | Buy |
+10,593
| New | +$83K | ﹤0.01% | 5262 |
|